Prevalence and incidence of chemotherapy-induced taste alterations in adult cancer patients: a systematic review protocol.
Journal
JBI evidence synthesis
ISSN: 2689-8381
Titre abrégé: JBI Evid Synth
Pays: United States
ID NLM: 101764819
Informations de publication
Date de publication:
01 05 2022
01 05 2022
Historique:
pubmed:
25
2
2022
medline:
31
8
2022
entrez:
24
2
2022
Statut:
epublish
Résumé
This study will synthesize the available evidence on the prevalence and incidence of chemotherapy-induced taste alterations in adult cancer patients. Taste and smell alterations in cancer patients due to chemotherapy affect patients' quality of life and can cause malnutrition. Recent knowledge about the incidence and prevalence of chemotherapy-induced taste alterations may enable tailored food interventions for this specific population. Describing variations in taste changes in subgroups of chemotherapy is important to inform taste steering interventions. The review will consider studies that include adult cancer patients who are receiving or have received chemotherapy as a treatment for an oncologic issue. It will include studies that investigate the prevalence and incidence of chemotherapy-induced taste alterations that have been assessed objectively or subjectively by patient-reported outcomes. A systematic search will be performed of the following databases: MEDLINE (PubMed), CINAHL (Ovid), Embase, and OpenSIGLE. Analytical, observational, and cross-sectional studies will be considered. All studies will undergo critical appraisal, data extraction, and synthesis. Data will be extracted using the JBI standardized data extraction tool for prevalence and incidence. Type and frequency of treatment and cytostatic agent will be extracted. The population will be described by age and gender. In addition, study methods and proportions of interest to the review question will be extracted. Pooled prevalence estimates will be calculated using a random effects model. PROSPERO CRD42020136706.
Identifiants
pubmed: 35199656
doi: 10.11124/JBIES-21-00197
pii: 02174543-202205000-00008
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1338-1343Informations de copyright
Copyright © 2022 JBI.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2021;71 (3):209–249.
Belgian Cancer Registry. Flemish region: females, number of invasive tumours by primary site and age group in 2014 [internet]. 2016 [cited 2021 Feb 12]. Available from: http://www.kankerregister.org/media/docs/SKRstats/2014/2014-F-FLE-Abs.pdf .
Pugnaloni S, Vignini A, Borroni F, Sabbatinelli J, Alia S, Fabri M, et al. Modifications of taste sensitivity in cancer patients: a method for the evaluations of dysgeusia. Support Care Cancer 2020;28 (3):1173–1181.
Amezaga J, Alfaro B, Ríos Y, Larraioz A, Ugartemendia G, Urruticoechea A, et al. Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Support Care Cancer 2018;26 (12):4077–4086.
van Oort S, Kramer E, de Groot J-W, Visser O. Taste alterations and cancer treatment. Curr Opin Support Palliat 2018;12 (2):162–167.
Hartley IE, Liem DG, Keast R. Umami as an ‘alimentary’ taste. A new perspective on taste classification. Nutrients 2019;11 (1):182.
Witt M. Anatomy and development of the human taste system. Handb Clin Neurol 2019;164:147–171.
Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis and approach to assessment and management. Oral Oncol 2010;46 (2):77–81.
Epstein JB, de Andrade ESSM, Epstein GL, Leal JHS, Barasch A, Smutzer G. Taste disorders following cancer treatment: report of a case series. Support Care Cancer 2019;27 (12):4587–4595.
Holbrook EH, Meyers AD, Leopold D, Talavera F, Tewfik T, Noell C, et al. Disorders of taste and smell [internet]. Medscape; 2021 [cited 2021 Feb 25]. Available from: https://emedicine.medscape.com/article/861242-overview .
Boltong A, Keast R, Aranda S. Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment. Support Care Cancer 2012;20 (11):2765–2774.
Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: a cross-sectional study. BMJ Open 2016;6 (11):1–10.
Doty RL. Age-related deficits in taste and smell. Otolaryngol Clin North Am 2018;51 (4):815–825.
Boyce JM, Shone GR. Effects of ageing on smell and taste. Postgrad Med J 2006;82 (966):239–241.
de Vries YC, Boesveldt S, Kelfkens CS, Posthuma EE, van den Berg MMGA, de Kruif JTCM, et al. Taste and smell perception and quality of life during and after systemic therapy for breast cancer. Breast Cancer Res Treat 2018;170 (1):27–34.
Zabernigg A, Gamper E-M, Giesinger JM, Rumpold G, Kemmler G, Gattringer K, et al. Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist 2010;15 (8):913–920.
Minakata Y, Yamagata T, Nakanishi H, Nishimoto T, Nakanishi M, Mune M, et al. Severe gustatory disorder caused by cisplatin and etoposide. Int J Clin Oncol 2002;7 (2):124–127.
PDQ Supportive and Palliative Care Editorial Board. Oral complications of chemotherapy and head/neck radiation (PDQ ® ): health professional version [internet]. PDQ Cancer Information Summaries; 2016 [cited 2021 May 21]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65881/ .
Murtaza B, Hichami A, Khan AS, Ghiringhelli F, Khan NA. Alteration in taste perception in cancer: causes and strategies of treatment. Front Physiol 2017;8:134.
Gibbons JR, Sadiq NM. Neuroanatomy, neural taste pathway [internet]. StatPearls; 2021 [cited 2021 Jun 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545236/ .
Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS, et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 2010;18 (8):1081–1087.
Boltong A, Keast R. The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 2012;38 (2):152–163.
Corremans M, Goossens E, Adriaenssens J, Mortelmans D, Geurden B. A qualitative study about cancer outpatients’ experiences with selective taste control of bread as a self-care intervention. Nurs Open 2021;00:1–7.
Walliczek U, Negoias S, Hahner A, Hummel T. Assessment of chemosensory function using “sniffin’ sticks”, taste strips, taste sprays, and retronasal olfactory tests. Curr Pharm Des 2016;22 (15):2245–2252.
Kano T, Kanda K. Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 2013;40 (2):E79–85.
Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T, et al. Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 2003;41 (1):2–6.
Kenne Sarenmalm E, Browall M, Gaston-Johansson F. Symptom burden clusters: a challenge for targeted symptom management. A longitudinal study examining symptom burden clusters in breast cancer. J Pain Symptom Manage 2014;47 (4):731–741.
Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Chapter 5: Systematic reviews of prevalence and incidence. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis [internet]. Adelaide: JBI, 2020 [cited 2021 May 21]. Available from: https://synthesismanual.jbi.global .
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6 (7):e1000100.
National Institute for Health Research. Prevalence of chemotherapy-induced taste alterations in adult cancer patients: a systematic review protocol [internet]. 2020 [cited 2021 May 21]. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020136706 .